Can IL6R rs2228145 AA and TNF rs1800629 AG bias cytokine signaling toward stronger inflammatory responses?

Genetic variations in key inflammatory pathways can intrinsically shift baseline cytokine activity, creating a biological bias toward heightened systemic inflammation.

Genetic mechanisms of cytokine bias

• IL6R rs2228145 AA: This homozygous genotype reduces the proteolytic shedding of the membrane-bound IL-6 receptor (mIL-6R), resulting in significantly lower circulating levels of soluble IL-6 receptor (sIL-6R). The resulting higher density of mIL-6R on cell surfaces biases cellular signaling toward stronger classical IL-6 signaling responsiveness.
• TNF rs1800629 AG: This heterozygous -308 G>A promoter variant functionally enhances transcriptional promoter activity, establishing a "high-producer" phenotype characterized by elevated baseline and inducible TNF-alpha levels.

Downstream biomarker manifestations

• Ferritin: Heightened IL-6 signaling directly stimulates hepatic hepcidin synthesis—which downregulates ferroportin to cause cellular iron sequestration—while simultaneously upregulating ferritin gene transcription, elevating this key acute-phase reactant.
• Red Cell Distribution Width (RDW): Chronically elevated IL-6 and TNF-alpha restrict iron availability for erythropoiesis, blunt bone marrow responsiveness to erythropoietin, and impair erythroid progenitor maturation. This disrupted process yields highly heterogeneous red blood cell sizes, manifesting as increased RDW.
• Mean Platelet Volume (MPV): These pro-inflammatory cytokines act as thrombopoietic stimulants, accelerating megakaryocytopoiesis and platelet turnover. This typically leads to the release of larger, more reactive platelets into circulation, elevating MPV.

Bottom line

• The IL6R rs2228145 AA and TNF rs1800629 AG genotypes functionally bias signaling toward heightened classical IL-6 and TNF-alpha responses, which directly align with above-optimal ferritin, RDW, and MPV through cytokine-driven iron sequestration, impaired erythropoiesis, and accelerated platelet turnover.